Anaplastic thyroid carcinoma: a nationwide cohort study on incidence, treatment and survival in the Netherlands over 3 decades.
Mischa de RidderEls Nieveen van DijkumAnton EngelsmanEllen KapiteijnHeinz-Josef KlümpenCoen R N RaschPublished in: European journal of endocrinology (2020)
ATC is rare, but often lethal, form of thyroid cancer, with a median survival of 2 months and 1-year survival of approximately 10%. The incidence is slightly rising in the Netherlands over the past 3 decades. There appears to be a subgroup of patients that survive longer, mainly those with relatively limited disease who underwent double or triple therapy. Further research is needed to define these patients more distinctively.